Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

被引:133
作者
Becker, B
Multhoff, G
Farkas, B
Wild, PJ
Landthaler, M
Stolz, W
Vogt, T
机构
[1] Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany
[2] Univ Regensburg, Dept Hemtol Oncol, D-93053 Regensburg, Germany
[3] Univ Regensburg, Dept Pathol, D-93053 Regensburg, Germany
[4] Med Univ Pecs, Dept Dermatol, Pecs, Hungary
关键词
melanoma; heat-shock protein 90; Hsp90; immunotherapy;
D O I
10.1111/j.0906-6705.2004.00114.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The heat-shock protein Hsp90 has been shown to be essential for the functional integrity of the telomerase complex. The telomerase activity is enhanced in melanoma and stabilizes the chromosomal integrity in proliferating cells. Furthermore, overexpression of Hsp90 induces silencing of point mutations in transcription factors which, otherwise, would result in a loss-of-function phenotype. In melanocytic lesions there is a higher risk of mutations caused by the enhanced proliferation in melanocytic cells. By analyzing microdissected melanocytic tumors by semiquantitative PCR, we demonstrate an overexpression of Hsp90 mRNA in malignant melanomas (10/14) and in melanoma metastases (6/6) as well as in melanoma cell lines (9/9) when compared with melanocytic nevi (2/9). These results could be confirmed on protein level by immunohistochemistry. While melanocytic nevi show discrete Hsp90 expression only in a minor fraction (2/9), malignant melanomas and metastases show a positive Hsp90 immunohistochemistry in the majority of cases; (7/9) and (13/14), respectively. In addition, by analyzing melanoma metastases by flow cytometry we show that Hsp90 is expressed on the surface of tumor cells (7/8). From these data we conclude that Hsp90 is present in advanced malignant melanomas and may have a stabilizing effect on the cellular functions in proliferating cells of melanocytic lesions and could thereby be a prerequisite for the tumor progression. As Hsp90 is expressed on the cell surface, it might also be a potential immunorelevant target structure for immunotherapy of melanoma.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 36 条
[21]  
Piselli P, 1995, J BIOL REG HOMEOS AG, V9, P55
[22]   CONSTITUTIVE EXPRESSION OF THE HEAT-SHOCK PROTEIN 72-KDA IN HUMAN-MELANOMA CELLS [J].
PROTTI, MP ;
HELTAI, S ;
BELLONE, M ;
FERRARINI, M ;
MANFREDI, AA ;
RUGARLI, C .
CANCER LETTERS, 1994, 85 (02) :211-216
[23]   Hsp90 as a capacitor of phenotypic variation [J].
Queitsch, C ;
Sangster, TA ;
Lindquist, S .
NATURE, 2002, 417 (6889) :618-624
[24]   Hsp90 as a capacitor for morphological evolution [J].
Rutherford, SL ;
Lindquist, S .
NATURE, 1998, 396 (6709) :336-342
[25]   Stress proteins and immunity mediated by cytotoxic T lymphocytes [J].
Schild, H ;
Arnold-Schild, D ;
Lammert, E ;
Rammensee, HG .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (01) :109-113
[26]   DISRUPTION OF THE RAF-1-HSP90 MOLECULAR-COMPLEX RESULTS IN DESTABILIZATION OF RAF-1 AND LOSS OF RAF-1-RAS ASSOCIATION [J].
SCHULTE, TW ;
BLAGOSKLONNY, MV ;
INGUI, C ;
NECKERS, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24585-24588
[27]   Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol [J].
Sharma, SV ;
Agatsuma, T ;
Nakano, H .
ONCOGENE, 1998, 16 (20) :2639-2645
[28]  
Smith DF, 1998, PHARMACOL REV, V50, P493
[29]   Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway [J].
Soga, S ;
Kozawa, T ;
Narumi, H ;
Akinaga, S ;
Irie, K ;
Matsumoto, K ;
Sharma, SV ;
Nakano, H ;
Mizukami, T ;
Hara, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :822-828
[30]   Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world [J].
Srivastava, PK ;
Menoret, A ;
Basu, S ;
Binder, RJ ;
McQuade, KL .
IMMUNITY, 1998, 8 (06) :657-665